EXPERT ASSESSMENT OF THE CURRENT RANGE OF MEDICINAL PRODUCTS FOR TOPICAL THERAPY OF GINGIVITIS

Abstract

Given its high prevalence and impact on quality of life, gingivitis is important not only for healthcare but also to the broader social sphere. According to medical care protocols, various methods of treating gingivitis are used, depending on its type, course, and severity. The treatment primarily involves systematic oral hygiene measures combined with the use of topical medications with antimicrobial and anti-inflammatory properties, and the ability to slow the formation of bacterial biofilms. The aim of this study. The study aims to characterize the current range of medicines classified under group A01A, «Drugs for use in dentistry», that are indicated for the treatment of gingivitis, according to their medical use instructions, and to conduct an expert evaluation of these medicines. Materials and Methods. The study was based on data from the State Register of Medicines of Ukraine, instructions for medical use, and scientific publications. Methods included information retrieval, comparative analysis, a system-analytical approach, and a survey methodology. Conclusion. As of January 1, 2024, 39 medicinal products from group A01A, «Drugs for use in dentistry», were registered in the Ukrainian pharmaceutical market for the local treatment of gingivitis, according to their medical use instructions. These products were classified based on their origin and composition of active ingredients, dosage form, country of manufacture, and prescription status. A questionnaire survey conducted among dentists examined the availability of information on modern drugs for topical gingivitis treatment, their perception of new medications, and the influence of various factors on prescription practices. Based on average scores for efficacy, safety, and frequency of use, a ranked list of medicines was formed. This list can serve as a tool for optimizing the pharmaceutical supply for gingivitis patients.